Atlas FDA

AUGMENT BONE GRAFT

FDA premarket approval P100006 · decided 2015-09-01

Approval details

PMA number
P100006
Trade name
AUGMENT BONE GRAFT
Generic name
Filler, bone void, synthetic peptide
Applicant
Biomimetic Therapeutics, LLC
Date received
2010-02-04
Decision date
2015-09-01
Days to decision
2035 days
Decision code
APPR
Product code
NOX
Advisory committee
Orthopedic
Expedited review
No
Location
Franklin, TN
Statement
APPROVAL FOR AUGMENT® BONE GRAFT. THIS DEVICE IS INDICATED FOR USE AS AN ALTERNATIVE TO AUTOGRAFT IN ARTHRODESIS (I.E., SURGICAL FUSION PROCEDURES) OF THE ANKLE (TIBIOTALAR JOINT) AND/OR HINDFOOT (INCLUDING SUBTALAR, TALONAVICULAR, AND CALCANEOCUBOID JOINTS, ALONE OR IN COMBINATION), DUE TO OSTEOARTHRITIS, POST-TRAUMATIC ARTHRITIS, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AVASCULAR NECROSIS, JOINT INSTABILITY, JOINT DEFORMITY, CONGENITAL DEFECT, OR JOINT ARTHROPATHY IN PATIENTS WITH PREOPERATI

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.